Skip to main content
OpenTrials
Completed

NCT Number: NCT02246283

Schizophrenia for "Life" - a Registry and Interview Study Among Elderly With Lifelong Schizophrenia

The elderly demographic is on the rise - and this includes elderly living with schizophrenia. Yet very little is known about their lives, how they cope with their condition and how it develops over time.

Research in this patient-group is sparse; overall there seem to be a tendency for elderly patients to manifest fewer psychotic symptoms and experiencing an increase in the psychological quality of life with older age. Opinions are divided on the degree and extent to which this tendency reflects remission and/or recovery in older patients.

In order to identify factors associated with a positive outcome we:

* Investigate the course and the outcomes of the illness over the lifespan, as well as the life course and outcomes. * Investigate the current status of mental and physical health, quality of life as well as functional competence of elderly (55+ yr) with schizophrenia.

Also the investigators

- Compare the trajectory and prognosis of schizophrenia (a chronic mental illness) with type 1 diabetes (a chronic somatic illness).

This study will yield vital insights into how schizophrenia develops over time, isolating factors that determine how well patients fare. The perspective is to advance knowledge of elderly with schizophrenia with a view to optimizing and increasing the effectiveness of the interventions offered to this group.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Schizophrenia Mental Disorders Schizophrenia Spectrum and Other Psychotic Disorders

Age range

55 year–95 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Unit of Psychiatry, Psychiatric Unit Odense - University function

Odense C, 5000, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Initial schizophrenia diagnosis between the ages 18-40 (both incl) in the period 1970-1979 (both incl) Interview study: Residence in Region of Southern Denmark

Exclusion criteria

Interview study: Mental retardation

-

Treatment and study plan

Primary outcomes

  1. Ageing with schizophrenia

    Time frame: up to 45 years

    Prognosis measured by use of healthcare system, use of medicine, co-morbidity, mortality, causes of mortality, and socio-demographic data, including highest level of education, years of employment/un-employment, use of health- and welfare services.

Secondary outcomes

  1. Quality of life

    Time frame: 1 month

    Questionnaire

  2. Remission

    Time frame: 6 months

    Questionnaire

Sponsors and collaborators

Lead sponsor

Kjeld Andersen

Other

Collaborators

  • Butcher Max Wørzner and wife Inger Wørzner's Memorial Grant
  • Jeppe Juhl and Ovita Juhls Memorial Grant
  • Odense Patient Data Explorative Network
  • Region of Southern Denmark
  • The Danish Health Foundation (Helsefonden)
  • The Danish Mental Health Foundation
  • The Psychiatric Research Foundation in Southern Denmark
  • The non-profit foundation Trygfonden.
  • University of Southern Denmark

Registry information

Important dates

Study start
2013
Primary completion
2015
Study completion
2017
First posted
Sep 22, 2014
Registry last updated
Jul 17, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.